Hundreds of diseases that cause scarring or inflammation in your lungs are known as interstitial lung disease (ILD)—also called pulmonary fibrosis. All of these diseases make it more difficult to ...

Pulmonary fibrosis (PF) is a type of interstitial lung disease that causes lung tissue to scar, thicken, and stiffen. It can make breathing difficult and interfere with oxygen absorption into the ...

Winning its second FDA approval this year, Boehringer Ingelheim's oral drug Jascayd is now cleared for use in the U.S. by ...

PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging, with variable criteria across studies. Risk factors for PPF include older age, male sex, smoking, ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

In a phase 3 study, nerandomilast administered at 18 mg or 9 mg twice daily slowed the progression of pulmonary fibrosis in adults with progressive pulmonary fibrosis. In a previous study, ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung condition. IPF causes scar tissue to build up in the lungs, leading to shortness of breath and a persistent cough. According to ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...